David Solomon

61PUBLICATIONS
162CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Feb 06, 2026
A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.

Jiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky

|May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification.

Cynthia Hawkins, Kenneth Aldape, David Capper

|Mar 07, 2025
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.

Eduardo Rodriguez Almaraz, Geno A Guerra, Nadeem N Al-Adli

|Nov 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.

Calixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young

|Nov 13, 2024
Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma.

Huimin Geng, Shirley Mo, Lingjing Chen

|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution.

Calixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo

Pageof 11

Frequent Collaborators

13 joint publications

Arie Perry

9 joint publications

Joanna Phillips

8 joint publications

David Raleigh

8 joint publications

Calixto-Hope Lucas